AUTL earnings date and last-quarter result: next report 2026-08-11, last quarter beat, P/E -1.32. Updated 2026-07-23.
Autolus Therapeutics (AUTL) Research Hub
Autolus Therapeutics (AUTL) trades on NASDAQ, GB in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 1.53 USD (-0.65%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1.32, market cap 0.38B. This hub links to the full technical, earnings and options research available for AUTL.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, GB |
| Last close | 1.53 USD (-0.65%) |
| 52-week range | 1.39 USD – 2.58 USD |
| Trend regime | Range |
| 14-day RSI | 31.9 (Bearish) |
| Trailing P/E | -1.32 |
| Market cap | 0.38B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-11 |
Available research for AUTL
Covered Call on AUTL: how it works, illustrative setup around the real 1.53 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on AUTL: how it works, illustrative setup around the real 1.53 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on AUTL: how it works, illustrative setup around the real 1.53 USD price, max profit/loss, breakeven and when to use it. Educational.
AUTL technical analysis: range, last 1.53 USD, RSI 31.9, 52w range 1.39 USD–2.58 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is AUTL in?
Autolus Therapeutics (AUTL) is classified under Healthcare (Biotechnology), listed on NASDAQ, GB.
Is AUTL in an uptrend or downtrend?
As of 2026-10-26, AUTL is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is AUTL's trailing P/E ratio?
AUTL's trailing P/E is -1.32, with a market cap of 0.38B. See the earnings research page for full valuation detail.
When does AUTL next report earnings?
AUTL is next scheduled to report earnings on 2026-08-11.